参考文献/References:
[1] Raherison C, Ouaalaya EH, Bernady A, et al. Comorbidities and COPD severity in a clinic-based cohort. BMC Pulm Med,2018,18(1): 117.
[2] 中华医学会呼吸病学分会慢性阻塞性肺疾病学组. 慢性阻塞性肺疾病诊治指南(2013年修订版). 中华结核和呼吸杂志,2013,36(4):255-264.
[3] Global initiative for chronic obstructive pulmonary disease. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease(2020 REPORT).[EB/OL].[2019-12-20].https://goldcopd.org/gold-reports/.
[4] Rutten EPA, Lenaerts K, Buurman WA, et al. Disturbed intestinal integrity in patients with COPD: effects of activities of daily living. Chest,2014,145(2): 245-252.
[5] Sprooten RTM, Lenaerts K, Braeken DCW, et al. Increased Small Intestinal Permeability during Severe Acute Exacerbations of COPD. Respiration,2018,95(5): 334-342.
[6] Ge Z, Li B, Zhou X, et al. Basic fibroblast growth factor activates beta-catenin/RhoA signaling in pulmonary fibroblasts with chronic obstructive pulmonary disease in rats. Mol Cell Biochem,2016,423(1-2): 165-174.
[7] Chiu CJ, McArdle AH, Brown R, et al. Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolic reappraisal. Arch Surg,1970,101(4): 478-483.
[8] Geltser BI, Kurpatov IG, Kotelnikov VN, et al. Chronic obstructive pulmonary disease and cerebrovascular diseases: functional and clinical aspect of comorbidity. Ter Arkh, 2018, 90(3): 81-88.
[9] Raftery AL, Tsantikos E, Harris NL, et al. Links Between Inflammatory Bowel Disease and Chronic Obstructive Pulmonary Disease. Front Immunol,2020,11: 2144.
[10] Brassard P, Vutcovici M, Ernst P, et al. Increased incidence of inflammatory bowel disease in Quebec residents with airway diseases. Eur Respir J,2015,45(4): 962-968.
[11] Vutcovici M, Bitton A, Ernst P, et al. Inflammatory bowel disease and risk of mortality in COPD. Eur Respir J, 2016, 47(5): 1357-1364.
[12] Lee J, Im JP, Han K, et al. Risk of inflammatory bowel disease in patients with chronic obstructive pulmonary disease: A nationwide, population-based study. World J Gastroenterol,2019,25(42): 6354-6364.
[13] Otani T, Furuse M. Tight Junction Structure and Function Revisited. Trends Cell Biol,2020,30(10): 805-817.
[14] Fukui H. Increased Intestinal Permeability and Decreased Barrier Function: Does It Really Influence the Risk of Inflammation? Inflamm Intest Dis,2016,1(3): 135-145.
[15] 李百强,武之洋,袁晨晨,等.鱼油代谢物保护素D1对重症急性胰腺炎小鼠肠粘膜损伤保护作用的研究 . 肠外与肠内营养,2020,(4):205-210.
[16] Vancamelbeke M and Vermeire S. The intestinal barrier: a fundamental role in health and disease. Expert Rev Gastroenterol Hepatol,2017,11(9): 821-834.
[17] 李百强,袁晨晨,董 杰,等.柚皮素对脂多糖诱导的脓毒症小鼠肠粘膜损伤保护作用研究.肠外与肠内营养,2020,(3):181-186.
[18] Lee B, Moon KM, Kim CY. Tight Junction in the Intestinal Epithelium: Its Association with Diseases and Regulation by Phytochemicals. J Immunol Res,2018,2018: 2645465.
[19] Ronaghan NJ, Shang J, Iablokov V, et al. The serine protease mediated increase in intestinal epithelial barrier function is dependent on occludin and requires an intact tight junction. Am J Physiol Gastrointest Liver Physiol,2016,311(3): G466-479.
[20] Haines RJ, Beard RS Jr, Eitner RA, et al. TNFalpha/IFNgamma Mediated Intestinal Epithelial Barrier Dysfunction Is Attenuated by MicroRNA-93 Downregulation of PTK6 in Mouse Colonic Epithelial Cells. PLoS One,2016,11(4): e0154351.
[21] Meckel K, Li YC, Lim J, et al. Serum 25-hydroxyvitamin D concentration is inversely associated with mucosal inflammation in patients with ulcerative colitis. Am J Clin Nutr, 2016, 104(1):113-120.
相似文献/References:
[1]李百强,袁晨晨,董 杰,等.柚皮素对脂多糖诱导的脓毒症小鼠肠粘膜损伤保护作用研究[J].肠外与肠内营养杂志,2020,(03):181.[doi:DOI : 10.16151/j.1007-810x.2020.03.012]
LI Bai-qiang,YUAN Chen-chen,DONG Jie,et al.Protective effect of naringenin on intestinal mucosal injury in mice with lipopolysaccharide-induced sepsis[J].PARENTERAL & ENTERAL NUTRITION,2020,(01):181.[doi:DOI : 10.16151/j.1007-810x.2020.03.012]
[2]李百强,武之洋,袁晨晨,等.鱼油代谢物保护素D1对重症急性胰腺炎小鼠肠粘膜损伤保护作用的研究[J].肠外与肠内营养杂志,2020,(04):205.[doi:10.16151/j.1007-810x.2020.04.004]
LI Bai-qiang,WU Zhi-yang,YUAN Chen-chen,et al.Protective effect of protectin D1 inhibitor on intestinal mucosal injury in mice with severe acute pancreatitis[J].PARENTERAL & ENTERAL NUTRITION,2020,(01):205.[doi:10.16151/j.1007-810x.2020.04.004]
[3]吴 丹,陈强谱.慢性阻塞性肺疾病相关肌少症的诊断与治疗[J].肠外与肠内营养杂志,2021,(05):308.[doi:10.16151/j.1007-810x.2021.05.010]
WU Dan,CHEN Qiang-pu.Diagnosis and treatment of chronic obstructive pulmonary disease-related sarcopenia[J].PARENTERAL & ENTERAL NUTRITION,2021,(01):308.[doi:10.16151/j.1007-810x.2021.05.010]